Furthermore, the patterns of TP53 mutations observed in cBioPortal data inform our understanding of prognosis and therapeutic responses, offering potential avenues for targeted treatments and personalized medicine approaches in lung cancer [128,130,190,192,193,194,195,196]. Here, TP53 is linked to lung carcinoma.